Semaglutide is a widely popular GLP-1 receptor agonist used for the management of type 2 diabetes and obesity
Electrolytes for Hydration Support Staying hydrated can be more challenging on GLP-1 medications than many people expect
In the FIGHT trial on patients hospitalized for HFrEF, Liraglutide did not show benefit on time to death, time to rehospitalization for heart failure, and time-averaged proportional change in N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels from baseline to 180 days [51]
While completely preventing weight regain is difficult, you can minimize it by tapering gradually instead of stopping abruptly, prioritizing protein (0.8 to 1g per pound of body weight daily), implementing consistent resistance training 2 to 4 times weekly, continuing to monitor food intake and body weight, staying highly active (250+ minutes weekly), maintaining eating patterns developed during treatment, and potentially staying on a low maintenance dose long-term
All'epoca stava scrivendo una tesi di laurea sui farmaci Glp-1